Project Grant F32CA306369
- The Regents of the University of Michigan received a $682,272 Project Grant from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to assess the feasibility and acceptability of a multifaceted, EHR-integrated mobile health intervention following radical cystectomy procedures. This award will fund the development and testing of a novel digital health application designed to monitor patient convalescence, facilitate patient-provider communication, and deliver...
- This Project Grant award of $135,990.00 from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) supports a cross-sectional, comparative research study to investigate cognition, vascular function, and physical activity in colorectal cancer survivors (CRCs) compared to matched controls. The study aims to: 1) Compare cognitive processing speed, carotid-femoral pulse wave velocity, and moderate-to-vigorous physical activity levels between CRCs and controls; 2) Examine the...
- This $2,864,671 federal Project Grant award was provided by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to the Regents of the University of Michigan for the project "Understanding and Harnessing Microbial Reprogramming to Combat Carcinogenic Colibactin in Colorectal Cancer". The key objectives are to: (1) develop a novel strategy to enzymatically inhibit colibactin, a procarcinogenic metabolite from gut bacteria associated with colorectal cancer, and (2)...
- The Project Grant award of $637,596.00 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) aims to develop and test a video-based intervention to reduce defensive cancer information avoidance and increase the reach of colorectal cancer screening messaging. The intervention is designed to increase self-efficacy and positive affect among those who typically avoid colorectal cancer information, with the goal of improving screening rates. The project includes a...
- This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $319,505 to the Regents of the University of Michigan to build nationwide investigator capacity in methods for adapting and personalizing cancer control interventions. The project aims to address the growing demand among cancer control researchers for new methodological skills in constructing adaptive interventions, which tailor evidence-based protocols to individuals' changing needs,...
- This federal Project Grant award of $157,980 from the National Cancer Institute's (NCI) Cancer Research Manpower program (CFDA 93.398) supports research by Dr. Jonathan Rennhack at Loyola University of Chicago's Health Sciences Campus. The goal is to better understand the critical molecular pathways and microenvironmental signals that drive metastasis in colorectal cancer, with a focus on elucidating the role of B-catenin/TCF signaling and gene expression in liver and lung metastases. This...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to the Regents of the University of Michigan provides $509,246 to conduct research aimed at understanding the early drivers of prostate cancer lineage plasticity. The research seeks to identify key transcriptional regulators that can repress androgen receptor signaling and activate alternate differentiation programs, as these factors are believed to be critical early drivers of the lineage...
- The National Cancer Institute (NCI) awarded a $772,418 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to St. Jude Children's Research Hospital Inc. on September 1, 2025. The grant, titled "Evaluation of Cardiovascular Health Outcomes among Survivors 2 (ECHOS-2)," will test the efficacy of an eHealth-delivered intervention to improve adherence to cardiomyopathy screening among adult survivors of childhood cancer. The intervention aims to address the...
- The National Cancer Institute (NCI) awarded a $183,309 Project Grant to Wayne State University on August 1, 2025 under the Cancer Research Manpower (CFDA 93.398) program. The grant supports a 5-year research project to investigate the socio-genomic factors associated with survival outcomes among a population-based sample of women diagnosed with endometrial cancer in metropolitan Detroit. The project aims to analyze how chronic stress and sociodemographic stressors may modify the relationship...
- This $8,473,624.00 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to develop and evaluate a patient navigation intervention to improve transition success among young adult survivors of childhood cancer who face multiple disadvantages. The research is being conducted by Children's Hospital Los Angeles, a prominent pediatric academic medical center and research institution. The goal is to address the significant...
This $165,080 federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower Program) will support a study to examine rates of guideline-concordant surveillance among young colorectal cancer survivors in Michigan. The study will utilize state cancer registry and administrative claims data to understand clinical and demographic factors associated with non-receipt of recommended surveillance (Aim 1). The researchers will also interview a cohort of young colorectal cancer survivors diagnosed from 2018-2022 to further explore their survivorship care needs (Aim 2). The award was granted to the Regents of the University of Michigan and has an expected completion date of August 31, 2027. This study aims to provide much-needed population-based estimates to inform supportive care strategies for young colorectal cancer survivors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $82.5k | 8/5/25 | ||
| Not listed | $0 | 8/5/25 | ||
| Not listed | $82.5k | 8/5/25 |